Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase NA 1 Phase 4 1

Status

Unknown 12 Recruiting 4 Completed 4 Not yet recruiting 2 Withdrawn 1 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Radiosurgery 20 Magnetic Resonance Spectroscopy 20 Exercise 15 Biopsy 11 Surveys and Questionnaires 9 Standard of Care 9 Cyclophosphamide 9 Educational Status 8 Practice Guidelines as Topic 7 Doxorubicin 7 Cisplatin 7 Therapeutics 6 Radiotherapy 6 Methods 6 Fluorodeoxyglucose F18 6 Early Intervention, Educational 6 Blood Specimen Collection 6 Radiotherapy, Intensity-Modulated 5 Electroporation 5 Cryosurgery 5 Colonoscopy 5 X-Rays 4 Water 4 Vincristine 4 Polymerase Chain Reaction 4 Palliative Care 4 Irinotecan 4 Drug Therapy 4 Diet Therapy 4 Cryotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Withdrawn × apatinib × Clear all

NCT03228043 2024-11-14

Apatinib for Resectable Colorectal Cancer

Nanchong Central Hospital

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡